Ibio, INC.
biotechnology & biomanufacturing company,developing therapeutics,vaccines and biomaterials
Based in TX
AI Overview
With $220K in lobbying spend across 9 quarterly filings, Ibio, INC is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $10K |
| 2021 | $120K |
| 2022 | $90K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ibio, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, MED, Budget/Appropriations
Advance iBio as the leader in plant-made pharmaceutical manufacturing and collaboration between the U.S. Government for research and manufacturing including funding for facilitation of domestic vaccin
Specific focus on plant-made pharmaceutical manufacturing of vaccines, and therapies, and funding for research and direct manufacturing with the U.S. Government or other commercial partners.
FY22 funding for advanced manufacturing technologies that utilize agricultural cell line development.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.